Organization · Private Equity
Windham Capital Partners
Windham Capital Partners is a New York City-based growth equity firm focused on investing in healthcare technology companies, particularly in therapeutic medical technology and digital health.
Overview
What Windham Capital Partners does
What Windham Capital Partners is
Windham Capital Partners is a New York City-based growth equity firm focused on investing in healthcare technology companies, particularly in therapeutic medical technology and digital health.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Structured capabilities
- Funder
- Last reviewed
- March 4, 2026
Official channels
Find Windham Capital Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Windham Capital Partners as a funder
Investment thesis
Windham Capital Partners invests in HealthTech companies developing innovative solutions in pharmaceuticals, medical devices, and digital health. They emphasize evidence-based technologies that are transformative or superior to existing solutions.
Focus narrative
Windham Capital Partners invests in HealthTech companies that are developing innovative solutions in the pharmaceutical, medical device, and digital health markets. The firm targets companies that are beyond the concept development stage, addressing significant healthcare challenges and demonstrating promising technology or products.
Focus and fit
- Stages
- Seed+ · Series A · Series B · Growth Equity
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 8
Portfolio context
Notable portfolio companies include: Delfi Diagnostics: Developing proprietary liquid biopsy-based diagnostic technology for early cancer detection. Alto Neuroscience: A biopharmaceutical company focused on integrating patient biology into drug development for mental health conditions. Nuvaira: Developing a novel bronchoscopic device for treating lung diseases, including COPD. Andros: An NCQA-certified SaaS company automating the provider credentialing process for healthcare providers and payors. Blueprint Health: A mentorship-driven startup accelerator for health technology entrepreneurs. CVRx: A clinical-stage company with technology for treating hypertension and heart failure. Cureatr: Providing medication management telepharmacy services to address suboptimal medication management. ControlRad: Focused on reducing radiation exposure during medical procedures.
Common questions
What to know about Windham Capital Partners
Upseed classifies Windham Capital Partners under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 4, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.